Zometa, Zomera, Aclasta and Reclast, Zoledronic Acid

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

66 API Suppliers, 26 USDMF, 10 CEP/COS, 8 JDMF, 11 EU WC, 7 KDMF, 11 NDC API, 46 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

222 FDF Dossiers, 56 FDA Orange Book, 67 Europe, 15 Canada, 24 Australia, 13 South Africa, 47 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAVENOUS - EQ 4MG BASE/100ML, INJECTABLE;INTRAVENOUS - EQ 4MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 1 Faran Shimi Pharmaceutical, 1 Gangwal Healthcare, 1 Pfanstiehl, 4 Actylis, 1 BASF, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 2 Kerry, 2 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 11 Chewable & Orodispersible Aids, 10 Direct Compression, 10 Taste Masking, 7 Disintegrants & Superdisintegrants, 6 Parenteral, 5 Co-Processed Excipients, 3 Granulation, 2 Controlled & Modified Release, 1 Solubilizers, 1 Thickeners and Stabilizers